Vanrx’s Robotic Machines for Drug Industry Catch Eye of U.S. Med Giant

Chris Procyshyn kept hearing a common refrain when he began talking to potential customers about the robotic machines his B.C. company was developing.
“‘It sounds too good to be true,’” recalled the CEO of Vanrx Pharmasystems Inc., who co-founded the Burnaby-based company in 2007.

The machines — capable of safely filling liquid drugs into vials, syringes and cartridges – have since gained enough industry confidence to attract attention from more than a few medical giants.

And this month Vanrx became the first-ever acquisition completed by Cytiva since Danaher Corp.’s (NYSE:DHR) take-over of GE Life Sciences last year in a US$21.4-billion deal.

GE Life Sciences subsequently rebranded as Cytiva.

PwC facilitated the Cytiva-Vanrx deal. Terms of the deal were not disclosed. Read the full article by Tyler Orton here, on Business in Vancouver.

Contact:

Email: torton@biv.com

Twitter: @reporton